Early breast tomosynthesis adopter Washington Radiology Associates increased cancer detection by one-third, decreased call-backs, and improved provider confidence.
At Washington Radiology Associates, staying on the leading edge of women’s imaging technology is a priority, so the group wanted to be an early adopter of 3-D breast tomosynthesis.
The six-location group in the Washington, DC area eventually replaced all 15 of their Hologic Selenia 2-D mammography machines with the Hologic Dimensions product, on which they could add the tomosynthesis software.
After a three month trial with two tomography upgrades, “our doctors were convinced this technology was beneficial for our patients,” said Patrick Waring, administrator for Washington Radiology Associates. Last June, the group completed the upgrade of 15 Dimensions 3-D tomography machines.
Washington Radiology Associates has chosen to charge customers a fee, since it’s not yet a reimbursable service. Tomosynthesis is offered to all patients - not just those with dense breasts, for example - and a large percentage of patients choose tomo, Waring said.
Radiologists at Washington Radiology Associates have increased their cancer detection rate by about a third, said Mark Klein, MD. Call-back rates have also diminished, depending on the radiologists, but likely on average about a third, too.
Equally important, Klein said, is the reduced anxiety for the radiologist that comes with reading a study with greater certainty. “Your confidence level goes way up,” he said. “When you’re finished reading a 3-D mammogram and you think it’s normal, you’re probably right. That’s a real advantage.”
In addition to the benefits to radiologists and patients, the addition of tomosynthesis is a differentiator for the practice. “If you’re not the first [to offer tomosynthesis], the guy down the street will be,” Waring said. “This is technology that will be here to stay.”
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.